FT-4202, a selective pyruvate kinase R activator for sickle cell disease.
Ericsson A, Richard DJ, Wilker E, Lancia JDR, Fessler S, Troccolo P, Zheng X, Toms A, Dinsmore C, Yao L, Kuypers FA, Larkin S, Marcotte D, Fulzele K, Ribadeneira M, Guichard SM, Marshall G.
Ericsson A, et al.
Exp Hematol. 2024 Nov 14:104673. doi: 10.1016/j.exphem.2024.104673. Online ahead of print.
Exp Hematol. 2024.
PMID: 39549740
Free article.
Anemia in patients with sickle cell disease (SCD) increases 2,3-diphosphoglycerate (2,3-DPG), decreasing hemoglobin-oxygen (Hb-O(2)) affinity to improve oxygen offloading and promote hemoglobin polymerization (sickling) of red blood cells (RBCs). ...
Anemia in patients with sickle cell disease (SCD) increases 2,3-diphosphoglycerate (2,3-DPG), decreasing hemoglobin-oxygen (Hb …